Pfizer, Celgene and Baxter were among the investors in the cancer drug developer's latest round, boosting its funding to $93m in total.

Newcastle University spinout Orla Protein Technologies's collaboration with Japan Radio Co raises more investment to carry on developing its infectious sample detector.

Stanford University cancer screening spinout CAPP Medical has been acquired by Roche.

Shareholder Johnson & Johnson bought stock in the molecular diagnostics technology provider as it floated in Brussels at a valuation of more than $500m.

Ligand acquired a 37% share in the biopharmaceutical company, which is set to float on Nasdaq, issuing three million shares priced at $8.00 each.

A Maryland University spinout is working on portable artificial lungs after gaining the rights to the technology and receiving a $100,000 investment.

Oxford University genetic analysis spinout Genomics agrees to use its technology to work collaboratively with healthcare company Eisai in its drug discovery process.